NPPB and congestive heart failure: Studies have shown that the risk of CHF-related death is positively correlated with NT-proBNP levels (Cao et al., 2019), so the proportion of patients with a decrease in serum NT-proBNP of more than 30% was chosen as the primary outcome for this study.